Pulmonary Hypertension Trial, Recruiting NCT06081881 Sponsor: Ester Ashraf Faried Beshay Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06081881
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with an acute pulmonary embolism (a blood clot in the lungs)
  • You are between 18 and 80 years old
  • Your condition has been assessed using a scoring tool (called PESI or sPESI) and your score falls into a moderate-to-high risk category (confirm with trial site)

Who may not be able to join:

  • You have high blood pressure in your lungs that is caused by another underlying condition (rather than the blood clot itself)
  • You have severe kidney problems, based on a specific kidney function test result (confirm with trial site for exact values)
  • You have a liver condition or liver damage
  • You are unable to take blood-thinning medications for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ester A Faried, Resident, Assiut University

Phone: 01277194352

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ester Ashraf Faried Beshay
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Incidence of CTEHP in symptomatic patients after pulmonary embolism episode.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov